GGrantIndex
Sort

59,101 grants matching hypertension

Sex-specific Risk for Vascular Dysfunction and Cognitive Decline

$1,089,542
Virginia M Miller · Mayo Clinic Rochester · P50 · FY2015 · AG

Clinical Applications of Nitrite and Nitrate

$1,089,316
Alan Schechter · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK

Sex-specific Risk for Vascular Dysfunction and Cognitive Decline

$1,088,692
Virginia M Miller · Mayo Clinic Rochester · P50 · FY2016 · AG

Progesterone in the Treatment of ischemic Stroke

$1,088,678
Donald G Stein · Emory University · U01 · FY2012 · NS

JACKSON HEART STUDY

$1,088,379
Asoka S Srinivasan · Tougaloo College · N01 · FY2010 · HL

Kansas PKD Research and Translation Core Center

$1,088,089
James P Calvet · University Of Kansas Medical Center · P30 · FY2015 · DK

Cardiovascular Health and Needs Assessment in Washington D.C.

$1,085,472
Tiffany Powell · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL

Mechanical Load Effects on Cardiac Function and Heart Diseases

$1,085,383
Ye Chen-Izu · University Of California At Davis · R35 · FY2024 · HL

Long-Term Neural Determinants of Cardiovascular Diseases

$1,085,178
John W Osborn · University Of Minnesota · R01 · FY2007 · HL

Clinical validation of NS-0200, a fixed combination drug product for the treatment of hypertension

$1,084,359
Michael B. Zemel · Nusirt Sciences, Inc. · R44 · FY2025 · HL

Pathophysiology of Myocardial Disease

$1,083,084
Wendy S Post · Johns Hopkins University · T32 · FY2023 · HL

MRI, Cognitive, Genetic & Biomarker Precursors of AD & Dementia in Young Adults

$1,082,810
Philip A Wolf · Boston University Medical Campus · R01 · FY2012 · AG

Center of Excellence on Race, Ethnicity and Health Disparities Research

$1,082,246
Stephen B. Thomas · Univ Of Maryland, College Park · P20 · FY2016 · MD

Development of MRI microvascular biomarkers in cognitive impairment and dementia

$1,082,071
Hanzhang Lu · Johns Hopkins University · UH2 · FY2017 · NS

Comprehensive CVD Risk Reduction Trial in Persons with Serious Mental Illness

$1,081,789
Gail L Daumit · Johns Hopkins University · R01 · FY2012 · HL

Regulation Of Intracellular Iron Metabolism

$1,080,971
Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2014 · HD

Cognitive Function, Alzheimer's Disease and Related Disorders in the HAALSI Cohort

$1,080,765
Lisa F Berkman · Harvard School Of Public Health · R01 · FY2018 · AG

MOLECULAR EPIDEMIOLOGY OF ESSENTIAL HYPERTENSION

$1,079,567
University Of Texas Hlth Sci Ctr Houston · R37 · FY2001 · HL

Epidemiology of Sleep-Disordered Breathing in Adults

$1,079,487
Terry B Young · University Of Wisconsin-Madison · R01 · FY2010 · HL

Genetics of Alzheimer's Disease in Israeli Arabs

$1,078,448
Robert Paul Friedland · University Of Louisville · R01 · FY2009 · AG

2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)

$1,078,320
Maria Mori Brooks · University Of Pittsburgh At Pittsburgh · U24 · FY2020 · HL

HyperGEN: Genetics of Left Ventricular Hypertrophy

$1,077,617
Donna K. Arnett · University Of Kentucky · R01 · FY2016 · HL

Development of a novel disease modifying oral therapy for pulmonary arterial hypertension.

$1,077,584
Jaipal Singh · Vasculonics, Llc · R44 · FY2024 · HL

Marinobufagenin as a therapeutic target

$1,077,564
Edward Lakatta · National Institute On Aging · ZIA · FY2024 · AG

Genomic Predictors of Arteriosclerosis in Hypertensives

$1,077,080
Sharon L Kardia · University Of Michigan At Ann Arbor · R01 · FY2008 · HL